Integrate the best available genetic evidence into your drug discovery and development
Differentiated R&D Value
with Human Genetic
Foresight
Integrate world-class genetic insights into drug discovery and development decisions with differentiated expertise, platforms, and analytics.
Drugs with supporting genetic evidence are 2.6x more likely to result in a successful medicine.
Our latest research published in Nature, expands upon our previous publication, showing that the increasing wealth of genetic and genomic evidence significantly enhances the likelihood of clinical success, with improvements of over 2x in most disease areas and up to 4x in metabolic disease.
“Genetic evidence provides a human causal relationship between a potential drug target and the disease we hope to treat. It is the most effective means to improve drug discovery and development success rates and improve R&D efficiency.”
– Matt Nelson, PhD, Genscience CEO
Our Work
— Nature 2024
Refining the impact of genetic evidence on clinical success
— PLOS Genetics 2025
Human genetic evidence enriched for side effects of approved drugs
– Nature Reviews Genetics 2016
The genetics of drug efficacy: opportunities and challenges
– PubMed Central 2020
Network and pathway expansion of genetic disease associations identifies successful drug targets
– Nature Genetics 2015
The support of human genetic evidence for approved drug indications
The Field-leading Platform for Genetic Analysis
Genetic Studies
Traits and Diseases
Genes with Genetic Evidence
Gene-Trait Combinations
World-Class Expertise
Genetic Evidence for Drug Discovery and Development
Platform
Data
Analytics
Workflows
Services
Differentiated Insights
Creative Solutions
Decision Driving
GENR8R
Integrated
Evidence
Guidance
Genscience:
Client Phenotypes
A Sampling of Our Clients and Phenotypes
Large Biotechs
Pharmas
Small Biotechs & Startups
Biotech VC Groups
